ColgatePalmolive (CL)
(Delayed Data from NYSE)
$105.79 USD
-0.13 (-0.12%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $105.80 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Price, Consensus and EPS Surprise
CL 105.79 -0.13(-0.12%)
Will CL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CL
Procter & Gamble (PG) Trades Near 52-Week High: Should You Buy?
Colgate (CL) Benefits From Innovation & Pricing Actions
CL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inter Parfums (IPAR) Q2 Earnings Top, Sales Up on Robust Demand
B&G Foods (BGS) Q2 Earnings Meet Estimates, Unit Volumes Dip
Molson Coors (TAP) Gains as Q2 Earnings & Sales Beat Estimates
Other News for CL
Stocks hitting all-time highs: JPM, KO, LMT, UNH, and more
My Dividend Stock Portfolio: New July Dividend Record - 101 Holdings With 24 Buys
Let's Have A Look At Buying Dividend Growth Stocks Without Looking, Almost 10 Years Later
Colgate-Palmolive Co: Is It A Buy?
Morgan Stanley’s 20 Top Stock Picks